Overview

Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension

Status:
Completed
Trial end date:
2000-09-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine the safety and efficacy of UT-15 in patients with severe symptomatic primary pulmonary hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
United Therapeutics
Treatments:
Treprostinil